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Abstract
Background: The development, implementation and evaluation of any new health intervention is complex. This
paper uses experiences from the design, implementation and evaluation of a rehabilitation programme to shed
light on, and prompt discussion around, some of the complexities involved in such an undertaking.
Methods: Semi-structured interviews were conducted with 15 trial participants and five members of staff at the
conclusion of a trial evaluating a rehabilitation programme aimed at promoting recovery after stem cell
transplantation.
Results: This study identified a number of challenges relating to the development and evaluation of complex
interventions. The difficulty of providing a standardised intervention that was acceptable to patients was
highlighted in the participant interviews. Trial participants and some members of staff found the concept of
equipoise and randomisation challenging and there was discord between the psychosocial nature of the
intervention and the predominant bio-medical culture in which the research took place.
Conclusions: A lack of scientific evidence as to the efficacy of an intervention does not preclude staff and patients
holding strong views about the benefits of an intervention. The evaluation of complex interventions should, where
possible, facilitate not restrict that complexity. Within the local environment where the trial is conducted,
acquiescence from those in positions of authority is insufficient; commitment to the trial is required.
Background
The development of the randomised controlled trial has
radically altered the way in which medical therapies are
developed, tested and administered. Since 1947 when
the Medical Research Council initiated what is generally
considered to be the first randomised and blinded clini-
cal trial [1,2] the principles of randomisation and con-
trol have moved from being controversial novelties to
expected normalities. In the 1990’s the broadening of
the concept of evidence based medicine towards evi-
dence based practice reflected a growing recognition of
the need for decisions about health care interventions to
be based on evidence of effectiveness.
However, there are obvious differences between the
evaluation of a new drug and, for example, the
evaluation of an intervention to promote recovery after
cancer treatment and it is not always possible to simply
extend the randomised controlled trial design. In
acknowledgment of this the Medical Research Council
developed in 2000 [3] and then revised in 2008 [4] gui-
dance for the development and evaluation of complex
interventions. The MRC emphasise the need for robust
and rigorous evaluation of complex interventions, pro-
moting the use of experimental methods, but providing
information on some of the alternatives to the conven-
tional randomised controlled trial and highlighting situa-
tions in which a trial is impractical or undesirable [4].
Given the current financial imperative for interventions
to be of proven benefit in order to compete for finite
resources, the focus on patient centred care and the
undisputed value of the randomised controlled trial it is
likely that the number of trials of complex interventions
will increase considerably. With this in mind we wanted
to provide comment on one randomised controlled trial
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of a complex intervention which was recently conducted
in order to explore some of the acknowledged and hid-
den complexities of this form of research.
This paper reports findings from a qualitative study of
the experiences of the development, implementation
and evaluation of a rehabilitation programme following
stem cell transplantation in a regional haematology unit.
A number of staff working on the unit had identified a
need for more structured rehabilitation that might
include not only support for patients’ physical problems
but also would address some of the perceived social and
psychological needs of these patients. A programme of
rehabilitation based on evidence from both the cancer
and cardiac rehabilitation literature (for example [5-7])
was put together by a small group of nursing and phy-
siotherapy staff working in collaboration with the rest of
the clinical team and patients who had previously
undergone stem cell transplant. The programme was
piloted by these staff members who felt it was a viable
model of routine service delivery and observed positive
effects among the small number of patients who under-
took the pilot programme. Since these results were
based on a small, uncontrolled sample and conducted
by those who had developed the intervention, the possi-
bility of bias is a legitimate concern. At this stage an
external research team was appointed to conduct an
independent and definitive study that attempted to
answer whether or not the programme was effective in
improving patient outcomes. This paper aims to shed
light on, and prompt discussion around, some of the
complexities involved in undertaking a randomised con-
trolled trial of two forms of rehabilitation (healthcare
professional led and self-managed).
Methods
The design of the evaluation was mixed-methods with a
qualitative interview study following the completion of
the randomised controlled trial. A full description of the
trial and the quantitative results are reported elsewhere
[8] but brief details are provided here to give context to
the qualitative study that is the focus of this paper.
The trial design chosen was a two-arm parallel study
comparing structured rehabilitation in a hospital setting
led by a team of health professionals (HPL programme)
with a home-based, self-managed rehabilitation pro-
gramme (SM programme). Participants were aged 18
years and over, and had been treated in the previous six
to eight weeks with an autologous or allogenic stem cell
transplant. The primary outcome was change in physical
functioning at six months. Potential participants were
initially approached by a healthcare professional and
then contacted by a member of the research team (LB)
and at this point if potential participants were happy to
take part they were asked to provide formal written
consent. Following consent and baseline data collection,
LB informed participants of their allocation after tele-
phoning an individual independent to the study team
who held the randomisation lists.
Participants randomised to the HPL programme were
asked to attend the hospital once a week for 10 weeks
to take part in a group session consisting of a tailored
exercise programme, and a relaxation and information
support session. Participants randomised to the SM pro-
gramme were given an information pack that contained
a home-based exercise programme and access to all the
information and relaxation exercises provided on the
HPL programme, this being a slight enhancement of the
standard care where rehabilitation was provided in a
less structured and more ad hoc manner. Patients could
not access the intervention outside of the trial.
During a 14-month recruitment period 144 potential
participants were approached about the trial and 61
(42%) consented to take part. Common reasons for
declining to take part were distance from home to hos-
pital, and that the programme did not seem relevant.
Fifty-eight people were randomised and 46 participants
were followed-up at six months. The main reasons for
drop out were disease relapse and death.
Qualitative interviews
Individual qualitative interviews to gather the rehabilita-
tion and trial experiences of those who took part in the
trial were included in the original study design. The
study design was revised to incorporate further indivi-
dual interviews with staff members in order to explore
their perspectives on the challenges that arose during
the trial. The interviews were all conducted by the same
researcher (LB) as had managed the trial. The researcher
had a background in nursing but did not have any clini-
cal role on the unit where the trial took place. The
study was approved by the North Nottinghamshire
Local Research Ethics Comittee (LREC reference num-
ber 05/Q2402/51).
Patient interviews
Interviews were conducted with 15 patients from within
the sample of 58 participants who took part in the trial
(see table 1). Participants were interviewed shortly after
the end of their involvement in the trial and interviews
explored patients’ experiences of rehabilitation and of
participation in a randomised controlled trial.
Maximum variation sampling was used to ensure that
the sample included women and men, individuals from
both arms of the trial, and across age groups. All partici-
pants approached to be interviewed agreed to partici-
pate. The interviews lasted between one to one and a
half hours and were conducted at a location convenient
for the participant. This tended to be in a quiet side
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room at the hospital or in the participant’s own home.
Topic guides covered life after transplantation, experi-
ences of rehabilitation, the acceptability of randomisa-
tion, the acceptability of the evaluation tools and overall
trial experience. The schedules served as a guide for the
interview structure and content but did not stipulate
exact phrasing of questions and prompts, or sequence of
areas of enquiry.
Staff interviews
Interviews were also conducted with five members of
staff, see table 1, after completion of the trial. All three
staff members who had been instrumental in designing
and implementing the health profession led programme
were interviewed. Two other individuals were also inter-
viewed and whilst they had no direct involvement in the
design or delivery of the healthcare professional led pro-
gramme, it was felt that these individuals were responsi-
ble for setting the priorities and ethos of the transplant
unit. All staff members approached to be interviewed
agreed to participate. The staff interviews explored atti-
tudes and beliefs about the rehabilitation programme
and about the appropriateness of evaluating it using a
randomised controlled trial. Interviews with members of
staff who had been involved in running the rehabilita-
tion programme explored the experience of providing
the rehabilitation programme within the context of a
randomised controlled trial. The interviews were con-
ducted during the working day in a location convenient
for the staff member, typically their own office or a
private meeting room. Topic guides were used to pro-
vide a structure for the interviews.
Analysis
The analysis of the qualitative data was guided by the
need to have a more contextual and enhanced [9]
understanding of the trial. All interviews were audio
recorded, transcribed verbatim and then analysed using
NVivo 8. A thematic content approach to data analysis
was used. Following transcription, the interview tran-
scripts were checked for accuracy, read for context and
then coded. Individual codes were then collapsed into
broader categories that could be generally divided
between the two main areas of enquiry (rehabilitation
and evaluation) that were the focus of this qualitative
study. Within these two areas, themes could be distin-
guished that helped to explain both commonalities and
differences in patient and staff perspectives. The analysis
was conducted by two of the authors (LB and AA) and
corroborated by the third (KC). In the findings section
quotes from trial participants are identified with a P fol-
lowed by a study number and then the abbreviation
HPL denoting that they were allocated to the healthcare
professional led programme or SM denoting that they
were allocated to the self-managed programme. Quotes
from staff are identified with an S followed by a study
number.
Results
Patients’ perceptions of the rehabilitation programmes
Despite being developed by staff in collaboration with
patients and having undergone a pilot phase to test fea-
sibility and acceptability, views of the healthcare profes-
sional led rehabilitation programme were mixed. Most
of those interviewed who had taken part in the HPL
programme were positive about the exercise component
of the programme. Many expressed some degree of
exhaustion after exercising, but this was temporary and
relieved by resting. However two participants reported
finding the exercises too exhausting and one
commented:
P123 (HPL) I personally felt that it had perhaps done
me more harm than good. And I perhaps thought it was
a bit early because I wasn’t coping with it very well.
It has been argued that bone marrow transplantation
is one of the most stressful treatments in cancer care
[10]. It was for this reason that a relaxation component
was included as part of the HPL programme. However
this was not a need perceived by all participants.
P117(SM) I tend to just take every day as it comes...
I’ve gone past that stage of worrying about things.
Some participants clearly felt uncomfortable with the
relaxation sessions and one suggested that taking part
was like being “subjected to sort of séances“ (P123HPL).






Participant Interviewees (n = 15)
Gender
Male 2 5 7
Female 5 3 8
Age
< = 50 3 4 7
> 50 4 4 8
Transplant type
Allograft 3 2 5
Autologous 4 6 10
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This participant who had not found the relaxation ses-
sions helpful said “I think a couple of [group members]
were nodding off. I thought for god’s sake try and keep
awake“ (P123) indicating that, for this participant, falling
asleep would have been undesirable and unacceptable.
However, in contrast another participant commented
that “I love doing that kind of thing, I could kind of fall
asleep“ (P326). While the relaxation component was not
universally popular some participants indicated that
relaxation sessions had been useful and requested assis-
tance with repeating the exercises at home. These were
often the participants who, prior to the intervention,
had been noticeably anxious or who had found the
transplant process to be traumatic.
In the interviews participants were given the opportu-
nity to comment on each of the information sessions
provided as part of the HPL programme. Participants’
reflections on the sessions were generally positive but
suggested that information was sometimes repetitive,
simply stating common sense, or given too late in the
transplant process.
P315 (HPL) But a lot of it was repetition and there
was a bit of déjà vu. I’d heard and seen a lot of it before.
The participants felt that recovery after stem cell trans-
plantation was a highly individual process. One example
of this was the reaction of different participants to one of
the information components which was led by a hospital
chaplain which looked at life after transplant. Partici-
pants’ feelings about the session varied considerably.
P326 (HPL): the guy who came from the church he was
quite interesting, talking about death and how people
feel about dying and how people think, that was interest-
ing. I can remember others but I think he was the most
interesting one.
P320 (HPL): We had the vicar and he was very nice,
but for me he was a bit intrusive and that was no fault
of his that was just you know the way that I felt about it.
Several participants allocated to the self managed pro-
gramme said that they had never attempted the exer-
cises while others indicated that they gave the exercises
a go but quickly lost interest. Reasons for this included
a lack of motivation to excercise, or a preference for
other activities such as gardening or walking the dog.
Those participants who reported not completing the
exercises said that they believed that their motivation
would have been increased if they had been allocated to
the HPL programme. Participants attributed this to two
factors: the support provided by a group environment
and a feeling of greater confidence exercising where
there were professionals available to prevent injury. In
contrast to this three participants suggested that they
found the programme appropriate and helpful and that
they had consistently completed the programme several
times a week for a period of many weeks. The differing
reactions of individuals to the exercises appeared to
relate to several factors. The exercises were completed
by those with a high level of motivation to return to a
previous state of fitness and by those who had previous
direct (for example army training) or indirect (for exam-
ple a close relative with experience of circuit training)
experience of exercise training.
P311(SM) I found them very good... I first looked at
them and thought this looks too easy, but, the situation I
was in at the time when I came out of hospital, nothing
was easy so they were very good overall. The balance
was excellent.
Between and within the two study groups, opinions on
the value of the intervention received were strongly
divided. This illustrates some of the difficulties inherent
in trying to develop rehabilitation interventions of this
sort. For many participants, initial enthusiasm was occa-
sionally followed by a need for greater flexibility. This
was particularly a problem for the ‘group’ nature of the
health profession led programme, which, by definition
was designed for a ‘typical’ recovery trajectory that did
not always suit individuals with varying needs that fluc-
tuated over time. Conversely, for those allocated to the
self-managed care group, a lack of contact with others
in the early stages of their rehabilitation meant those
with less personal support may have struggled to moti-
vate themselves.
Staff and patient perceptions of involvement in a trial
The understanding of the rationale for conducting a
randomised controlled trial varied between the staff
members interviewed. Some perceived a robust evalua-
tion to be the right thing to do in a climate of limited
financial resources. Others implied that they were
involved not because they wanted to find out if the
intervention worked but because they wanted to prove
that it worked. This is a subtle but important difference
in emphasis which had a number of implications on
how staff felt about the trial.
S4 It [the trial] was the right thing to try to do, yes, I
think that’s right because clearly it [the intervention]
involves expense, and the question is how much value it
had.
S3: we’ve had to go through that process [the RCT] and
I now appreciate that. Before I resented it [the need to
test a new intervention].
Such a belief in the inherent value of the healthcare
professional led programme led these staff to experience
disappointment over the outcome of the randomisation
process in particular cases. Staff involved in delivering
the HPL programme reported finding it very difficult
when participants that they perceived would particularly
benefit from the intervention were allocated to the self-
managed programme.
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S1 there were certain patients that we saw that, you
know, you were desperate for them to get the hospital led
programme.
The impact of this was that some members of staff
found both the trial experience and recruiting patients
burdensome and attributed problems with delivering the
HPL programme to the fact that a trial was being con-
ducted. One member of staff perceived the trial to place
a series of hurdles that patients had to overcome (such
as consent to trial participation and randomisation) to
access the HPL programme. As a result, disappointing
trial recruitment meant that fewer patients than antici-
pated were participating in the HPL at any one time,
meaning a small group size changed the very nature of
the programme; the staff member suggesting that “the
trial had killed the intervention” (S2).
A number of participants also held strong opinions
with regards to the two programmes. Several partici-
pants expressed their conviction that the HPL pro-
gramme was superior.
P315 (HPL): I was on the right arm of the trial. It did
things better for me.
P318 (SM): It was fair as you did, you know, being
picked out I suppose it is fair. It’s just that I were picked
out for the wrong one.
However not all participants felt that the HPL pro-
gramme was superior. One participant was allocated the
HPL programme but chose never to attend commenting
afterwards that they should have consented to take part
on the condition that they were allocated to the SM
programme.
The comments of both staff and patients highlight
that the rigour of trial design can easily cause confusion
and or dissatisfaction. That a member of staff commen-
ted that ‘the trial killed the intervention’ is particularly
interesting. Their perspective was that since the pilot
phase had in their opinion been a success it must have
been as a result of the trial that the difficulties arose.
However it could be argued that the relatively low
recruitment and the level of trial attrition were in fact
related primarily to the intervention rather than the
trial. More robust piloting of both the intervention and
of the recruitment and randomisation process may have
identified more accurately where the problems lay.
The Impact of Organisational Culture
It was consistently recognised by staff that due to the
nature of the conditions treated on the unit where the
research took place, a highly ‘technical’ culture existed.
It was suggested that this narrow focus on the biological
needs of patients resulted in an undervaluing of the psy-
chosocial aspects of health.
S5: “Some of the medics are focused on getting people
in and getting people out, and therefore spending half an
hour talking to somebody about psychological issues, um,
isn’t high on their cards.”
S4: “Well there probably is [a need for emotional reha-
bilitation] although I don’t know that we cater for that”.
This, it was argued, had important consequences for
how the service was delivered, the implementation of
the intervention, and the success of the trial. It was sug-
gested that this technical perspective somehow ‘rubbed
off’ on patients resulting in them experiencing a narrow-
ing of their own concept of health.
S2: “And I think they (patients) are probably focusing
very much on blood counts and whether they’ve got
GVHD [Graft Versus Host Disease] and if they’re doing
all right, and actually rehab is like one extra thing to
them, it’s like, almost like they’ve closed down the shutters,
they can’t take on any more, and they’re like, no actually
I’m fine, I’ll be all right, I’ll sort it out, and it’ll be okay”.
It was felt that despite the fact that the HPL pro-
gramme was developed in response to the lack of
emphasis on psychosocial care, the programme and its
evaluation were potentially undermined by the reluc-
tance of some staff to prioritise psychosocial care. Since
some members of the medical team did not place a high
priority on psychosocial support they likewise did not
prioritise a trial which was attempting to evaluate a
biopsychosocial intervention. This issue was a particular
problem since it was felt that patients were more likely
to take part in the trial if it was mentioned to them by a
member of medical staff. Without the support of the
whole medical team there was not the momentum to
promote and maintain trial recruitment. Furthermore,
for one member of staff, the trial put into sharp focus
the dynamics of the professional hierarchy that was
embedded in the local organisational culture.
S3: “these patients, everything they do, from, even
sometimes getting out of bed, they will say well we’ll do
it if the doctors say we’ll do it, because everything’s so
medically controlled, (...) patients do what the doctors
say...”
S2: “I’ve learned a lot, in terms of the sort of power
relations and how to get things done or not done. And I
would have thought before the trial, I was quite influen-
tial, and actually, when it actually comes to it, you rea-
lise you’re not that influential at all really.”
Discussion
This qualitative interview study has provided an insight
into both the way the two rehabilitation programmes
were experienced and the reality of conducting a rando-
mised controlled trial in a health service setting.
Although there are other good examples of this [11,12]
in the main, trial reports of the context of the interven-
tion(s) and the evaluation are limited. The artificiality of
the experimental process has been highlighted [13].
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The data in this study highlighted the numerous prac-
tical difficulties involved in trying to develop and evalu-
ate a complex intervention and that compromise is
often required between the optimum research design
and the practicalities of delivering health care in the real
world. The patient data in this study illustrated how dif-
ficult it is to develop and standardise a complex rehabi-
litation intervention so that it is acceptable to patients
with different needs and preferences. Hawe et al. [14]
suggest that too often a complex intervention is reduced
to its constituent parts in order for it to fulfil the strict
requirements of a randomised controlled trial. In effect
this results in a complex intervention being reduced to
a series of simple interventions and in doing so fails to
acknowledge that a complex intervention has the poten-
tial to be more than the sum of its parts [14]. Hawe
et al. suggest that inconclusive trials could be avoided if
standardisation of the function of an intervention rather
than of its form was more widely utilised. They suggest
that this would allow for context level adaption and
enable tailoring of the intervention to the local environ-
ment, which would potentially improve efficacy. In our
own study, a trial could have evaluated whether having
access to a patient centred rehabilitation service
improved patient outcomes as opposed to testing
whether a defined set of rehabilitation interventions
improved patient outcomes. The service could have
included a core set of interventions which were selected
and delivered in response to individual patient need.
This study found that some participants and staff felt
a sense of misgiving over the use of a randomised con-
trolled trial design to evaluate the rehabilitation pro-
grammes. Many patients and staff had clear preferences
and this meant that the concepts of equipoise and ran-
domisation were contentious. The fact that patients and
members of the general public find the concept of ran-
domisation and equipoise perplexing is widely acknowl-
edged [15-17] and advice exists [18] which aims to
assist in explaining this concept to potential trial partici-
pants. Whilst the benefit of the programme was unpro-
ven, some staff held strong personal beliefs about its
efficacy. It has been suggested that only 25% of medical
staff can envisage themselves being in personal equi-
poise and only 18% thought that their patients could be
in this state [19]. This raises a number of practical and
ethical issues. Collective equipoise may be the justifica-
tion for randomisation but staff who hold strong views
on the likely superiority of the effectiveness of one treat-
ment will have difficulty with seeing patients rando-
mised, while potential participants with clear
preferences are unlikely to agree to randomisation.
Although this is a potential problem in all trials, it is
often magnified in the evaluation of complex interven-
tions due to the necessary drive and determination of
individuals to bring about their development. It is
unrealistic to expect staff to take a neutral position in
relation to something that they have been instrumental
in creating.
Analysis of this qualitative data has highlighted that
difficulties in conducting the trial stemmed not just
from the challenges associated with the complexity of
the intervention but also from the complexity of the
local organisational culture. The importance of trial con-
text has been acknowledged particularly in relation to
complex interventions [3,20]. The impact that context
and culture can have on a trial has been highlighted in
seminal sociological works by Oakley [21] and Fox [22]
though trialists have perhaps failed to embrace this lit-
erature in a way that can fundamentally change the
approach taken to designing and implementing clinical
trials. Each person involved in a trial, whether they are a
participant, health professional or researcher, is influ-
enced by their own beliefs, attitudes and experiences
which consciously or unconsciously affect the way in
which they engage with the research process. This cre-
ates cultural expectations, both positive and negative,
which affect how other people engage with the trial.
This study found that organisational culture and under-
lying assumptions were rarely acknowledged and that
they only become apparent if they were challenged in
some way. Furthermore since those who determined the
cultural norms and ethos of the research environment
were ambivalent about the trial there was insufficient
commitment to support the considerable energy, time
and resource demands required for the trial to be a suc-
cess. The disparity in influence that members of differ-
ent healthcare professions exert has been well
documented [23,24] and here, the effects of this were
seen beyond healthcare delivery and into how research
agendas are set and enacted.
Strengths and limitations
Our sampling of trial participants and staff involved in
the delivery of the interventions have allowed both per-
spectives to be explored. Similarly, although we
acknowledge that our sample of staff is relatively small,
we have included accounts of both staff directly involved
in the trial and those only indirectly involved. In addi-
tion the challenges faced by both participants and
healthcare staff that were identified in these interviews
appear to have ‘relevance’ [25] to trials of complex
healthcare interventions beyond this particular trial in
this particular setting. A limitation of the study is the
lack of a voice for those who declined to take part in
the trial itself. For ethical and practical reasons we were
not able to approach any individual who had already
declined to take part in the trial. Another limitation of
this study is that the interviews were conducted by LB
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who was closely associated with the trial by both
patients and staff. This may have constrained intervie-
wees’ views on either the intervention(s) or the trial.
Transferability
Many of the issues in this paper relate to a particular
intervention, the way it was evaluated and the environ-
ment in which this took place. Despite this, many of the
issues discussed are pertinent to the evaluation of com-
plex health service interventions more generally. By defi-
nition complex interventions are difficult to standardise,
blind and regulate. Furthermore they are far more likely
to be developed as a result of the determination and
dedication of clinical staff, and need to be tested within
the competing pressures of the clinical environment.
Conclusions
A lack of scientific evidence as to the efficacy of an
intervention does not preclude staff and patients holding
strong views about the benefits of an intervention. The
evaluation of complex interventions should, where pos-
sible, facilitate not restrict that complexity. Although
MRC guidance on evaluating complex interventions [3]
provides a useful framework for the successful conduct
of trials of this sort, the evolution of interventions in
healthcare and their subsequent evaluation does not
always proceed in clearly defined stages. Within this
more fluid process, two elements appear crucial. First,
pilot studies should test the process of recruitment and
randomisation, examining the views and experiences of
staff and participants on this element of the research
process. The reality of randomising a service is often far
more difficult for healthcare providers than they antici-
pate. A more formal pilot study is unlikely to be con-
ducted without funding, but it has the advantage of
greater separation between the design and testing of the
intervention. Secondly, an understanding of the way a
particular service operates is not enough, an insight into
the organisational culture is necessary. Findings from
this study strongly suggest that within the local environ-
ment where the trial is conducted, acquiescence from
those in positions of authority is insufficient; commit-
ment to the trial is required.
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